Alpha Tau Medical Ltd.
NASDAQ:DRTSBiotechnology
+$0.04 today
- Market cap
- $1.11B
- Beta
- 1.20
- P/E (TTM)
- -15.2
- EPS (TTM)
- -$0.63
Volume 0.64M
Average 0.69M
DRTS Goodwill
The premium paid for acquisitions above the fair value of the identifiable net assets acquired.
Alpha Tau Medical Ltd.NASDAQ: DRTS
Goodwill · Q1 FY2026 · quarter ended Mar 2026
Goodwill remains negative
Q1 FY2026 goodwill was $0, compared with $0 a year earlier.
Context
- Goodwill amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Goodwill increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Goodwill history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Goodwill | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Goodwill vs competitors
How DRTS compares with its peers on the latest reported figures
- DRTS's Mar 2026 goodwill of $0 is the highest of the 3 companies compared; the peer median is $0.
- Goodwill amounts to 0.0% of total assets for DRTS, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding DRTS) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for DRTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 23.24M | 5.84M | 12.66M | 13.72M | 15.98M |
| Short-term Investments | 8.08M | 98.69M | 69.13M | 45.88M | 60.92M |
| Net Receivables | 480K | 32K | 19K | 332K | 36K |
| Inventory | (8.17M) | 0 | (19K) | 0 | 0 |
| Other Current Assets | 8.79M | 1.13M | 3.5M | 3.26M | 0 |
| Total Current Assets | 32.64M | 106.48M | 85.76M | 64.23M | 78.3M |
| Property, Plant & Equipment (Net) | 7.55M | 13.28M | 21.16M | 21.54M | 26.88M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 928K |
| Other Non-current Assets | 2.03M | 391K | 471K | 432K | 479K |
| Total Non-current Assets | 9.57M | 13.67M | 21.63M | 21.98M | 28.28M |
| Total Assets | 42.22M | 120.15M | 107.39M | 86.2M | 106.58M |
| Account Payables | 1.2M | 1.42M | 2.57M | 3.53M | 3.87M |
| Short-term Debt | 0 | 0 | 1.06M | 1.01M | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.41M | 1.34M | (983K) | 389K | 3.78M |
| Total Current Liabilities | 4.41M | 4.34M | 7.1M | 8.68M | 10.51M |
| Long-term Debt | 53.96M | 0 | 5.61M | 5.56M | 6.35M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 1.02M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 18.62M | 5.63M | 3.6M | 3.34M | 5.35M |
| Total Non-current Liabilities | 72.59M | 10.15M | 15.81M | 14.86M | 18.97M |
| Total Liabilities | 76.99M | 14.49M | 22.91M | 23.54M | 29.48M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (52.84M) | (86.6M) | (115.76M) | (147.51M) | (190.14M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | (34.78M) | 105.66M | 84.48M | 62.67M | 77.1M |
| Total Debt | 53.96M | 5.19M | 13.28M | 12.54M | 13.73M |
| Net Debt | 30.73M | (643K) | 619K | (1.19M) | (2.25M) |
Alpha Tau Medical Ltd.
NASDAQ:DRTS
Intrinsic Alpha fair value
Locked
Current Price
$12.01
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.